ACA
SLDB icon

Apis Capital Advisors’s Solid Biosciences SLDB Stock Holding History

Apis Capital Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Sell
160,000
-36,000
-18% -$231K 0.18% 38
2025
Q4 		$1.11M Hold
196,000
– – 0.19% 40
2025
Q3 		$1.21M Sell
196,000
-4,000
-2% -$23.4K 0.27% 39
2025
Q2 		$974K Buy
200,000
+90,000
+82% +$318K 0.35% 33
2025
Q1 		$407K Buy
+110,000
New +$471K 0.2% 41

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Apis Capital Advisors's SLDB Position: Q1 2026 in Review

Apis Capital Advisors reduced its Solid Biosciences (SLDB) stake by 18% in Q1 2026, selling an estimated $231K and leaving 160,000 shares worth $1.15M. The position accounts for 0.18% of the portfolio, ranked #38.

Apis Capital Advisors first reported a position in SLDB in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.21M in Q3 2025. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Apis Capital Advisors held 160,000 shares of Solid Biosciences worth $1.15M as of Q1 2026.
  • Apis Capital Advisors sold 36,000 Solid Biosciences shares in Q1 2026, an estimated $231K.
  • Solid Biosciences made up 0.18% of Apis Capital Advisors's portfolio in Q1 2026, its #38 holding.
  • Apis Capital Advisors first reported a position in Solid Biosciences in Q1 2025 and has held it in 5 quarters since.
  • Apis Capital Advisors's Solid Biosciences position peaked at $1.21M in Q3 2025.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Apis Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.